The country's medical technology sector, which has been identified as a sunrise sector with high government focus on development, is expected to touch USD 9.6 billion in 2022, a report said Monday.
The global medical technology market is also expected to reach USD 495 billion in the next three years, from the present USD 400 billion, PwC said in its report.
With the successful adoption of Medical Device Rules this year, the report said the Indian medical technology industry is finally seems to be coming of age and ready for the next phase of evolution.
"The domestic MedTech (medical technology) industry, estimated at USD 5.7 billion in 2017, is expected to grow to USD 7.8 billion in 2020 and USD 9.6 billion in 2022," the report said.
India has one of the lowest per capita spend of USD 4 on medical devices, much lower than global average of USD 66.3, which suggest huge potential for growth, it added.
Medical technology has been recognised as a sunrise sector by the government and 100 per cent foreign direct investment (FDI) investment has been allowed in this sector through the automatic route.
While the industry still remains largely import dependent, PwC expects new policy initiatives like 'Make in India' and support to FDI investments to help boost domestic manufacturing and export competitiveness of this industry.
The report said the government-industry collaboration has extended beyond medical device rules to include initiatives linked to standardisation.
Few other initiatives by the government include approval for two dedicated medical device testing labs for promoting research and development and approval to set up dedicated medical technology parks to promote manufacturing.
Going further, the PwC report noted that the industry seeks to continue exploring avenues for building more trust-based collaboration with the government.
The report pointed out that the government needs to further help promote development of this sector by considering initiatives such as having a separate Medical Device Act, Medical Device Regulator, Medical Device Department and Medical Device Export Promotion Council.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
